TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma, Nikkei has learned.
Business deals
Mitsubishi Chemical to negotiate with Bain to sell drug unit
Deal for Mitsubishi Tanabe Pharma could reach more than $3.2bn
Bain Capital and Mitsubishi Chemical Group are in talks over Tanabe Phama. (Source photos by Nikkei)
Read Next
.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Business deals
